Pharmarise Holdings Corporation

2796

JP3802320006

Drug Retailers

Market Closed - Japan Exchange Other stock markets 07:00:00 16/05/2024 BST			5-day change	1st Jan Change
654 ^JPY	-0.30%		-0.46%	-0.91%

04-11	Pharmarise Holdings’ Attributable Profit Down 15% in Fiscal Nine Months on Higher Expenses Following M&A	MT
04-10	Pharmarise Holdings Corporation Revises Consolidated Earnings Guidance for the Fiscal Year Ending May 31, 2024	CI

Pharmarise Holdings Corporation Provides Consolidated Earnings Guidance for the Fiscal Year Ending May 31, 2024

January 10, 2024 at 08:15 am

Pharmarise Holdings Corporation provided consolidated earnings guidance for the fiscal year ending May 31, 2024. For the period, the company expects net sales to be JPY 53,546 million, operating profit to be JPY 1,477 million, profit attributable to owners of parent to be JPY 449 million and earnings per share to be JPY 41.99.

Latest news about Pharmarise Holdings Corporation

Pharmarise Holdings’ Attributable Profit Down 15% in Fiscal Nine Months on Higher Expenses Following M&A	04-11	MT
Pharmarise Holdings Corporation Revises Consolidated Earnings Guidance for the Fiscal Year Ending May 31, 2024	04-10	CI
Tranche Update on Pharmarise Holdings Corporation's Equity Buyback Plan announced on January 11, 2024.	03-14	CI
Pharmarise Holdings Corporation announces an Equity Buyback for 1,416,800 shares, representing 12.07% for ¥1,032 million.	01-11	CI
Pharmarise's Fiscal H1 Attributable Profit Soars as Net Sales Rise	01-11	MT
Pharmarise Holdings Corporation authorizes a Buyback Plan.	01-10	CI
Pharmarise Holdings Corporation entered into stock transfer agreement to acquire GOOD AID Inc. from Kotoshino Co., Ltd. and Yuta Hattori.	01-10	CI
Pharmarise Holdings Corporation Provides Consolidated Earnings Guidance for the Fiscal Year Ending May 31, 2024	01-10	CI
Pharmarise Holdings Corporation Provides Dividend Guidance for the Fiscal Year Ending May 31, 2024	12/10/23	CI
Pharmarise Holdings Corporation Provides Consolidated Earnings Guidance for the Six Months and Full Year of Fiscal Year Ending May 31, 2024	12/10/23	CI
Pharmarise Holdings Corporation acquired Nine Dispensing Pharmacies in Tokyo, Niigata, and Fukushima.	09/08/23	CI
Pharmarise Holdings Corporation Provides Dividend Guidance for the Fiscal Year Ending May 31, 2024	11/07/23	CI
Pharmarise Holdings Corporation Announces Commemorative Dividend for the Fiscal Year Ending May 31, 2024	11/07/23	CI
Pharmarise Holdings Corporation Declares Dividend for the Fiscal Year Ending May 31, 2023, Payable on August 31, 2023	11/07/23	CI
Pharmarise Holdings Corporation Provides Consolidated Earnings Guidance for the Six Months and Full Year of Fiscal Year Ending May 31, 2024	11/07/23	CI
Pharmarise Logs 35% Drop in FY23 Nine-month Profit on Higher Utility Expenses, Lower Drugstore Sales	11/04/23	MT
Pharmarise Holdings Corporation Provides Consolidated Earnings Guidance for the Fiscal Year Ending May 31, 2023	10/04/23	CI
Pharmarise Holdings Corporation Provides Dividend Guidance for the Fiscal Year Ending May 31, 2023	10/04/23	CI
Pharmarise Holdings Corporation entered into basic agreement to acquire Two Dispensing Pharmacies in Mie Prefecture.	13/02/23	CI
Pharmarise Holdings Corporation Provides Consolidated Earnings Guidance for the Full Year of Fiscal Year Ending May 31, 2023	12/01/23	CI
Pharmarise Holdings Corporation Provides Dividend Guidance for the Fiscal Year Ending May 31, 2023	12/01/23	CI
Pharmarise's Fiscal Q1 Attributable Profit Soars 75%	14/10/22	MT
Pharmarise Holdings Corporation Provides Consolidated Earnings Guidance for the Six Months and Full Year of Fiscal Year Ending May 31, 2023	13/10/22	CI
Pharmarise Holdings Corporation Provides Dividend Guidance for the Fiscal Year Ending May 31, 2023	13/10/22	CI
Pharmarise Logs 5% Jump in FY22 Attributable Profit, Maintains Final Dividend	19/07/22	MT

Chart Pharmarise Holdings Corporation

Duration

Period

More charts

Company Profile

Pharmarise Holdings Corporation is a Japan-based holding company primarily engaged in the dispensing pharmacy businesses. Along with its subsidiaries and associated companies, the Company operates in five business segments. The Dispensing Pharmacy segment is engaged in the operation of dispensing pharmacies, which prescribe medicines to general patients based on prescriptions issued by medical institutions. The Merchandising segment consists of the cosmetics sales business, the convenience store management business and the drug store management business. The Medical Document Storage and Management segment is engaged in the storage and management of paper medical records and X-ray films. The Medical Mall Management segment is a business related to medical malls operated at JR Tower Office Plaza Sapporo in JR Sapporo Station. Others segment includes temporary staffing business and sales of stationery.

Sector

Drug Retailers

Calendar

10/07/2024 - Q4 2024 Earnings Release (Projected)

More about the company

	1st Jan change	Capi.
PHARMARISE HOLDINGS CORPORATION	-0.91%	47.64M
RAIA DROGASIL S.A.	-6.39%	9.06B
AIN HOLDINGS INC.	+31.18%	1.34B
QOL HOLDINGS CO., LTD.	-9.41%	364M
NIHON CHOUZAI CO.,LTD.	-0.21%	271M
SALUS, LJUBLJANA, D. D.	+13.33%	234M
GREEN CROSS HEALTH LIMITED	-9.17%	86.64M
MEDICAL IKKOU GROUP CO.,LTD.	+19.39%	60.56M

Retail - Drugs without Grocery